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muscle growth and metabolic dysfunction: Lessons from the heat-stressed  
pregnant ewe1
Dustin T. Yates,2 Jessica L. Petersen, Ty B. Schmidt, Caitlin N. Cadaret, Taylor L. Barnes,  
Robert J. Posont, and Kristin A. Beede 
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ABSTRACT: Intrauterine growth restriction 
(IUGR) is the second leading cause of perinatal 
mortality and predisposes offspring to metabolic 
disorders at all stages of life. Muscle-centric fetal 
adaptations reduce growth and yield metabolic 
parsimony, beneficial for IUGR fetal survival 
but detrimental to metabolic health after birth. 
Epidemiological studies have reported that IUGR-
born children experience greater prevalence of in-
sulin resistance and obesity, which progresses to 
diabetes, hypertension, and other metabolic dis-
orders in adulthood that reduce quality of life. 
Similar adaptive programming in livestock results 
in decreased birth weights, reduced and inefficient 
growth, decreased carcass merit, and substan-
tially greater mortality rates prior to maturation. 
High rates of glucose consumption and metabolic 
plasticity make skeletal muscle a primary target 
for nutrient-sparing adaptations in the IUGR 
fetus, but at the cost of its contribution to proper 
glucose homeostasis after birth. Identifying the 
mechanisms underlying IUGR pathophysiology is 
a fundamental step in developing treatments and 
interventions to improve outcomes in IUGR-born 
humans and livestock. In this review, we outline the 
current knowledge regarding the adaptive restric-
tion of muscle growth and alteration of glucose me-
tabolism that develops in response to progressively 
exacerbating intrauterine conditions. In addition, 
we discuss the evidence implicating developmental 
changes in β adrenergic and inflammatory systems 
as key mechanisms for dysregulation of these pro-
cesses. Lastly, we highlight the utility and import-
ance of sheep models in developing this knowledge.
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INTRODUCTION
Intrauterine growth restriction (IUGR) 
diminishes perinatal survival rates and encum-
bers long-term health in a substantial portion of 
the global population (Berghella, 2007; Saleem 
et al., 2011). It is second only to prematurity as a 
cause of perinatal mortality and morbidity (Alisi 
et  al., 2011) and predisposes affected persons to 
metabolic dysfunction throughout life (Hales and 
Barker, 1992, 2001). As early as 3 yr of age, IUGR-
born children exhibit greater rates of insulin resist-
ance, high blood pressure, and obesity than their 
average for gestational age (AGA) counterparts 
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(Flanagan et  al., 2000; Ong et  al., 2000; Mericq 
et al., 2005). By adulthood, their risk for developing 
metabolic disorders such as type 2 diabetes, obesity, 
and hypertension is increased by 18-fold (Barker 
et al., 1993; Gatford et al., 2010). In fact, IUGR is 
believed to be a predisposing factor in as many as 
half  of all clinical cases of metabolic syndrome (Vo 
and Hardy, 2012). Statistics confirm that IUGR 
is a global health issue, afflicting approximately 
25% of all infants worldwide (10% of U.S. infants; 
Berghella, 2007; Saleem et al., 2011). The most re-
cent perinatal data indicate that premature births in 
the United States have declined steadily for the last 
decade and the total rate of infant mortality is at a 
historic low (Murphy et al., 2017), yet the rate of 
IUGR births has remained steady since 2002; 20% 
greater than in the mid-1980s (Arias et al., 2003). 
Improved neonatal care has caused worldwide mor-
tality rates for IUGR infants to decline consider-
ably over the last several decades (Goldenberg and 
Culhane, 2007), which increases the need for a bet-
ter understanding of how IUGR fetal adaptations 
lead to metabolic deficiencies that shorten life span 
and decrease quality of life.
Postnatal consequences of  IUGR are not lim-
ited to humans and occur in most mammalian spe-
cies. In livestock, IUGR-induced low birthweight 
greatly increases perinatal mortality rates due to 
reduced energy reserves and lack of  vigor at birth 
(Reynolds and Caton, 2012; Dwyer et al., 2016). 
Consequently, the offspring are at a disadvantage 
during the first few months of  life. The lack of 
available information regarding how to manage 
these animals costs the U.S.  livestock industry 
~8% of  its annual product (Wu et al., 2006). This 
equates to a loss of  about 3 million beef  calves, 
930,000 dairy calves, and 530,000 lambs each year. 
Starvation deaths of  low birthweight livestock 
are a serious animal welfare issue for the industry 
and a barrier to financial sustainability for many 
producers. In addition, IUGR-born offspring that 
survive exhibit reduced efficiency and performance 
(Gondret et  al., 2005; De Blasio et  al., 2007) as 
demonstrated by reduced feed conversion, lighter 
carcasses, and reduced carcass merit (Hegarty and 
Allen, 1978; Powell and Aberle, 1980; Greenwood 
et al., 1998, 2000; Gondret et al., 2005). Greater 
metabolic dysfunction and perinatal mortality 
rates have also been documented in IUGR-born 
companion animals including dogs (Kliegman, 
1989) and horses (Peugnet et al., 2014) and in man-
aged wildlife species such as fallow deer (English 
and Mulley, 1992) and baboons (Pantham et al., 
2015; Li et al., 2017).
Barker’s thrifty phenotype hypothesis (Hales 
and Barker, 2001) states that metabolic deficits are 
the result of adaptive fetal programming aimed at 
sparing nutrients in response to placental insuffi-
ciency or other nutrient-restricting stressors. These 
adaptations create metabolic thrift in nonessen-
tial tissues (i.e., skeletal muscle) that is critical to 
in utero survival but detrimental after birth when 
nutrients are no longer restricted (Yates et  al., 
2011a, 2012b; Brown, 2014). Despite the well-es-
tablished epidemiological links between IUGR 
and life-long metabolic dysfunction, the underly-
ing adaptive mechanisms are not well understood. 
In this review, we discuss the existing knowledge 
regarding metabolic programming in the IUGR 
fetus, the essential contributions of sheep models to 
these discoveries, and the potential roles for adap-
tive changes in stress-system regulation of IUGR 
muscle growth and metabolism (Fig. 1).
PLACENTAL INSUFFICIENCY AND THE 
IUGR FETAL CONDITION
Placental Stunting
Clinical reports indicate that the majority of 
IUGR cases in humans are the result of placental in-
sufficiency (Cox and Marton, 2009). Maternal con-
ditions such as illness, stress, obesity, smoking, drug 
use, malnourishment, sleep disordered breathing, and 
even assisted reproduction technologies can stunt pla-
cental development (Carnelio et al., 2017; Woo et al., 
2017). Placental insufficiency resulting from any of 
these maternal etiologies reduces nutrient and oxygen 
delivery and causes predictably poor intrauterine 
conditions for the fetus. Similar placental stunting 
can occur in pregnant livestock as the result of en-
vironmental stress (i.e., heat, cold, altitude), under-
nourishment, illness, and ingestion of noxious plants 
(Greenwood and Cafe, 2007). Stress conditions often 
elevate maternal body temperature, redistributing 
blood flow away from the uterus to peripheral tissues 
(Alexander et al., 1987; Wallace et al., 2005). An in-
crease of as little as 1  °C can reduce uterine blood 
flow up to 30% (Dreiling et al., 1991), which if sus-
tained will reduce placental hyperplasia (Regnault 
et al., 2002) and disrupt vascular endothelial growth 
factor-regulated vascular development (Regnault 
et  al., 2002). The reduced number, diameter, and 
branching of placental arteries (Regnault et al., 2002) 
increases blood flow resistance 4-fold (Galan et al., 
2005; Regnault et al., 2007), which in turn decreases 
placental O2 permeability (Regnault et al., 2003; de 
Vrijer et al., 2004). Transport of glucose and amino 
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acids is also reduced by decreased placental expres-
sion of transporters for these nutrients (Malandro 
et al., 1996; Wallace et al., 2005; Jansson et al., 2006). 
Consequently, birthweight is strongly correlated with 
placental vascularization and mass (Pantham et al., 
2015; Poudel et al., 2015).
IUGR Fetal Pathophysiology
As the fetus outgrows its stunted placenta, typ-
ically in the early third trimester, it begins to exhibit 
hypoglycemia and hypoxemia that progressively 
worsen until birth (Macko et al., 2013). Umbilical O2 
and glucose concentrations are reduced by as much 
as 50% near term (Limesand et  al., 2007; Macko 
et al., 2016) despite normal concentrations in uterine 
blood. Placental transfer of amino acids is also 
markedly reduced (de Vrijer et al., 2004) by deficient 
active transport across the microvillous membrane 
(Malandro et al., 1996; Pantham et al., 2016). These 
deficits necessitate reductions in protein utilization 
by fetal tissues and in severe cases increase protein 
mobilization (Limesand et al., 2007; Rozance et al., 
2018). To illustrate, circulating leucine concentrations 
are maintained in the IUGR fetus because hindlimb 
utilization is reduced by 32% (Rozance et al., 2018). 
The greatest reductions are in utilization for protein 
synthesis and muscle growth, as leucine oxidation 
rates are comparable to normal fetuses.
In concert with worsening nutrient states, 
the IUGR fetus exhibits progressive increases 
in circulating norepinephrine and epinephrine 
(Macko et  al., 2013; Macko et  al., 2016). These 
catecholamines are secreted from the fetal adrenal 
in response to hypoxemia (Yates et  al., 2012a), 
which inactivates O2-sensing potassium channels 
on medullary chromaffin cells that normally block 
catecholamine exocytosis (Adams and McMillen, 
2000). Chronic hypoxemia also stimulates greater 
circulating inflammatory cytokines (Guo et  al., 
2010; Kelly et  al., 2017). At delivery, fetal cord 
blood from IUGR infants has greater concentra-
tions of  tumor necrosis factor α (TNFα), inter-
leukin-6 (IL-6), and interleukin-18 (IL-18), as well 
as the chemokine C-C motif  ligand 16 (CCL16) 
and the acute phase protein C-reactive protein 
(CRP) (Makikallio et al., 2012; Krajewski et al., 
2014; Visentin et al., 2014). In IUGR animal mod-
els, TNFα and IL-6 are elevated in late gestation 
(Bertucci et  al., 2011), and we recently reported 
that maternofetal inflammation due to maternal 
bacterial endotoxin injection at mid-gestation in 
rats results in smaller fetuses with increased cir-
culating TNFα at term, well after maternal bio-
markers of  inflammation had subsided (Cadaret 
et  al., 2017a). Reduced delivery of  nutrients can 
also increase fetal biomarkers of  inflammation 
late in gestation (Jones et  al., 2018). The adren-
ergic and inflammatory systems mediate many of 
the physiological changes affecting growth and 
metabolism in the IUGR fetus, and one prom-
inent mode of  action is inhibition of  growth 
Figure 1. Working model for the mechanistic link between maternofetal stress and the postnatal consequences of intrauterine growth restriction 
(IUGR).
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factors. Insulin, insulin-like growth factor (IGF)-I, 
IGF-II, and placental growth factor concentra-
tions are suppressed in the IUGR fetus by the 
mid-third trimester (Thorn et al., 2009; Leos et al., 
2010), as thoroughly reviewed by Laura Brown 
(2014). Catecholamines are particularly strong 
inhibitors of  insulin secretion, as norepinephrine 
infusion into otherwise uncompromised fetuses 
substantially reduces circulating concentrations 
(Chen et  al., 2014, 2017b), and fetal adrenal 
demedullation recovers glucose-stimulated in-
sulin secretion in acutely hypoxemic fetuses (Yates 
et al., 2012a) and in IUGR fetuses (Macko et al., 
2016). Moreover, inflammatory cytokines disrupt 
the ability of  IGF-I to interact with its receptor 
(Hashimoto et  al., 2010) and increase the levels 
of  IGF-binding proteins (IGFBP) (Street et  al., 
2006), which impedes the activity of  IGF through 
high-affinity binding (Hoeflich et al., 1999).
The conditions described above result in redis-
tributed fetal blood flow. The IUGR fetus directs 
more blood to the brain, heart, adrenal glands, and 
pancreas compared to the normal fetus (Alexander 
et al., 1987; Poudel et al., 2015). At the same time, 
catecholamines mediate femoral vascular resistance, 
resulting in an almost 50% decrease in hindlimb 
blood flow (Poudel et al., 2015; Rozance et al., 2018). 
Redirected blood flow prioritizes nutrient and O2 de-
livery to vital organs at the cost of restricted muscle 
growth, resulting in the hallmark asymmetric body 
composition of IUGR fetuses (Galan et al., 1999). 
Fetal growth restriction progressively worsens dur-
ing the later stages of gestation in parallel with its 
causative conditions (Carr et  al., 2012). Divergent 
growth starts early in the third trimester, just after 
characteristics of placental insufficiency begin to 
appear (Limesand et al., 2013; Macko et al., 2013). 
By midway through the third trimester, IUGR 
fetuses are ~28% lighter than uncompromised coun-
terparts (Bubb et al., 2007), and by term, growth re-
striction can exceed 50% (Leos et al., 2010; Rozance 
et al., 2015; Kelly et al., 2017).
Ovine Models of IUGR
A great deal of knowledge regarding IUGR 
fetal and neonatal pathology has been ascertained 
from pregnant sheep models. The fetal sheep’s 
tolerance of experimental conditions provides a 
means to characterize IUGR conditions in utero 
and has helped identify the nature and timing of 
developmental adaptations (Anthony et  al., 2003; 
Morrison, 2008; Yates et al., 2011a, 2012b). Sheep 
are the ideal ruminant model for low birthweight, 
as IUGR lambs share developmental characteris-
tics with IUGR calves and other ruminant species 
but experience reduced rates of prenatal and peri-
natal death (Anthony et  al., 2003). The smaller 
size, greater survival rates, and shorter gestation 
lengths allow IUGR lambs to be produced for re-
search more consistently and at about one-tenth the 
expense of IUGR calves. Low birthweight due to 
IUGR is a particularly common problem in swine 
due to the natural process of runting, which results 
from intrauterine crowding (Foxcroft et al., 2006). 
It should be noted that information learned from 
IUGR sheep is largely applicable to IUGR swine 
due to similar fetal pathophysiological conditions, 
despite noteworthy differences in litter size, relative 
myogenic milestones, and perinatal mortality rates 
between the two species (Wu et al., 2010; Oksbjerg 
et al., 2013). Fetal sheep also share developmental 
milestones for muscle growth and metabolic respon-
siveness with humans (Yates et al., 2012b), making 
them an appropriate model for biomedical research 
as well. Effective methods for creating or mimick-
ing placental insufficiency in sheep include maternal 
hyperthermia, uterine artery ligation, uteroplacen-
tal embolization, carunclectomy, maternal nutrient 
restriction, maternal overnutrition, fetal hormone 
infusion, and maternofetal hypoxia. Detailed com-
parisons among models are available (Anthony 
et  al., 2003; Wallace et  al., 2005; Vuguin, 2007; 
Morrison, 2008; Green et  al., 2010), but maternal 
heat stress is perhaps the most effective method to 
naturally induce placental stunting and IUGR. This 
model originated from observations in the early 
1950s of decreased birthweights and greater mor-
tality in summer-born compared to winter-born 
lambs in northern Australia (Morley, 1954; Moulk, 
1954). Controlled-environment studies soon con-
firmed that chronic exposure to high ambient tem-
peratures was indeed the impetus for smaller, less 
vigorous, summer-born offspring (Yeates, 1956; 
Shelton and Huston, 1968). Placental insufficiency 
is naturally produced when timed-pregnant ewes 
are exposed to high ambient temperatures and hu-
midity (typically 40 °C and 35% relative humidity) 
from mid-first trimester to late-second trimester, 
resulting in 0.7  °C to 1.5  °C increase in maternal 
body temperature (Yates et al., 2011a). In response, 
the ewe’s body increases heat expulsion by rerouting 
blood flow from the uterus and other deep organs 
to body surfaces (Alexander et  al., 1987; Thureen 
et al., 1992). The reduced blood supply stunts pla-
cental growth and development, which consistently 
reproduces the classic IUGR phenotype. The infor-
mation obtained from almost three decades of work 
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in this model has helped define IUGR fetal patho-
physiology and adaptive programming (Table 1).
PANCREATIC ISLET DEVELOPMENT AND  
β CELL FUNCTION
Pancreatic β cell dysfunction is a hallmark 
of  IUGR-born offspring and is a product of  dis-
rupted prenatal islet development (Green et  al., 
2010; Boehmer et al., 2017). Human IUGR fetuses 
develop smaller and less vascularized islets that 
contain fewer β cells (Van Assche and De Prins, 
1981), impairing insulin secretion during late ges-
tation (Nicolini et al., 1990), infancy (Bazaes et al., 
2003), childhood (Li et al., 2001), and adulthood 
(Jensen et al., 2002). Underlying islet pathologies 
have been characterized in detail in IUGR fetal 
sheep, which exhibit substantially less whole-pan-
creas and islet vascularity, basal insulin secretion, 
and glucose-stimulated insulin secretion near term 
(Limesand et al., 2006; Rozance et al., 2015). In add-
ition to reduced size, IUGR islets exhibit massive 
reductions in insulin content and glucose oxidation, 
the latter of  which mediates signaling-secretion 
coupling (Limesand et  al., 2006; Brown et  al., 
2016a). Interestingly, β cell development is dispro-
portionally reduced compared to other islet endo-
crine cells. Islets from IUGR fetal sheep islets have 
less insulin content, insulin-positive (β cell) area, 
and β cells per islet but have normal glucagon 
content and α and δ cell metrics (Limesand et al., 
2005; Limesand et al., 2013; Brown et al., 2016a). 
This is due to disruption of  β cell proliferative 
capacity, as IUGR β cells undergo normal rates 
of  apoptosis but exhibit substantial reductions in 
mitosis (Limesand et  al., 2005; Limesand et  al., 
2013; Brown et al., 2016a). Nutrient restriction is 
only indirectly responsible for islet pathologies, as 
fetal infusion of  nutrients or insulin does little to 
correct islet function. An exception is the partial 
restoration of  islet size and β cell sensitivity after 
sustained infusion of  high amount of  branched-
chain amino acids (Brown et  al., 2016a). Rather, 
hypoxemia and hypercatecholaminemia appear 
to be the primary contributors to islet dysfunc-
tion. Elevated circulating catecholamines in fetal 
sheep inhibit glucose-stimulated insulin secretion 
during both acute (Yates et al., 2012a) and chronic 
Table 1. Studies showing parallels in IUGR fetal pathology between sheep and humans
Pathology Sheep Human
O2 ~28% ↓ fetal arterial O2 at 0.7 
gestation; 30–50% ↓ fetal 
arterial O2 near term
Limesand et al., 2007; 
Limesand et al., 2013; 
Macko et al., 2013; 
Macko et al., 2016
~33% ↓ fetal arterial O2 at 
~0.75 gestation;15–40% ↓ 
cord blood O2 at delivery
Pardi et al., 1993; Roberts 
et al., 1999; Marconi 
et al., 2006
Glucose ~23% ↓ fetal arterial O2 at 
0.7 gestation; ~40% ↓ fetal 
arterial O2 near term
Limesand et al., 2013; 
Macko et al., 2013; 
Macko et al., 2016
~33% ↓ umbilical vein glucose 
in 3rd trimester; ~50% ↓ cord 
blood glucose at delivery
Economides et al., 1991; 
Roberts et al., 1999; 
Lee et al., 2010
Catecholamines 5 to 5.7-fold ↑ fetal arterial 
norepinephrine near term; 
~2.7-fold ↑ fetal arterial 
epinephrine near term
Limesand et al., 2007; 
Leos et al., 2010; 
Macko et al., 2013; 
Macko et al., 2016; 
Rozance et al., 2018
7.4-fold ↑ fetal arterial 
norepinephrine near term; 
3.1-fold ↑ amniotic fluid 
norepinephrine in third 
trimester
Divers et al., 1981; 
Greenough et al., 1990
Inflammation 5-fold ↑ fetal arterial IL-6 near 
term; 10-fold ↑ fetal arterial 
Activin A near term
Bertucci et al., 2011; 
Kelly et al., 2017; Jones 
et al., 2018
1.3 to 2.4-fold ↑ cord blood 
TNFα, IL-6, and IL-18 at 
delivery
Makikallio et al., 2012; 
Krajewski et al., 2014; 
Visentin et al., 2014
Insulin, IGF ~40% (basal) and 52% (glucose-
stim.) ↓ fetal arterial insulin 
near term; ~33% ↓ fetal 
arterial IGF-I near term
Bauer et al., 2003; Leos 
et al., 2010; Macko 
et al., 2016
~50% ↓ cord blood insulin 
at delivery; ~38% ↓ cord 
blood IGF-I at delivery; 
~13% ↓ cord blood insulin at 
delivery
Hubinont et al., 1991;  
Lee et al., 2010
Insulin action 1.6 to 2.4-fold ↑ perinatal 
insulin sensitivity; ~19% ↓ 
neonatal insulin sensitivity
Camacho et al., 2016a; 
Camacho et al., 2017; 
Merrick et al., 2017
3.7-fold ↑ perinatal insulin 
sensitivity; ~7% ↓ insulin 
responsive in neonatal 
muscle
Ozanne et al., 2005; 
Meral et al., 2011; 
Milovanovic et al., 
2014
Glucose oxidation 17–30% ↓ fetal glucose 
oxidation near term; ~33% ↓ 
neonatal glucose oxidation
Limesand et al., 2007; 
Brown et al., 2015; 
Merrick et al., 2017
~23% ↓ juvenile glucose 
oxidation
Jornayvaz et al., 2004
Myoblast function ~13% ↓ fetal myoblast 
proliferation; ~46% ↓ fetal 
myoblast differentiation; 
~12% ↓ neonatal myoblast 
proliferation
Yates et al., 2014; 
Camacho et al., 2016b; 
Riley et al., 2016
↓ Myonuclear content of 
gastrocnemius muscle
Widdowson et al., 1972
IGF, insulin-like growth factor; IL, interleukin; IUGR, intrauterine growth restriction; TNFα, tumor necrosis factor α.
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exposure (Chen et al., 2014; Macko et al., 2016). 
Moreover, sustained infusion of  norepinephrine 
into uncompromised fetal sheep recapitulates the 
IUGR phenotype for pancreatic islets, insulin con-
centrations, and fetal growth rates (Bassett and 
Hanson, 1998; Chen et al., 2014, 2017b). Surgical 
adrenal demedullation of  IUGR fetal sheep prior 
to the third trimester circumvented hypercatecho-
laminemia and partially recovered β cell sensitivity, 
islet function, and fetal growth near term despite 
presence of  fetal hypoxemia and hypoglycemia 
(Davis et al., 2015; Macko et al., 2016). In fact, ad-
renergic desensitivity after chronic exposure can 
cause β cells to oversecrete insulin when the ele-
vated adrenergic stimulation is reduced pharma-
ceutically (Leos et  al., 2010; Macko et  al., 2013; 
Chen et al., 2014, 2017a) or by birth of  the fetus 
(Camacho et  al., 2017). Paradoxically, basal ad-
renergic stimulation appears important for islet 
development; adrenal demedullation reduces basal 
and glucose-stimulated insulin secretion in con-
trol fetuses (Yates et al., 2012a; Davis et al., 2015; 
Macko et al., 2016) and fails to recover β cell mi-
tosis rates in IUGR fetuses (Davis et al., 2015). In 
addition, correction of  fetal hypoxemia improves 
glucose-stimulated insulin secretion in both intact 
and adrenal demedullated IUGR fetal sheep, indi-
cating catecholamine-independent as well as cat-
echolamine-mediated effects (Macko et al., 2016).
Heightened inflammatory activity also appears 
to mediate β cell function and fetal growth restric-
tion. In an unpublished preliminary study in sheep, 
maternal inflammation induced by serial bacterial 
endotoxin injection from days 100 to 113 of ges-
tation reduced glucose-stimulated insulin secretion, 
semitendinosus fiber size, and fetal weights at day 
125 of gestation, which is similar to rodent models 
of maternal inflammation (Cotechini et  al., 2014; 
Chen et al., 2015). Incubation of normal islets with 
inflammatory cytokines reduces glycolysis and 
glucose-stimulated insulin secretion (Oleson et al., 
2015), and RNA-seq data from IUGR fetal sheep 
islets indicate that they are desensitized to cytokine 
activity and binding (Kelly et al., 2017). Adrenergic 
and inflammatory suppression of insulin secretion 
helps explain the asymmetry of fetal growth restric-
tion, as hypoinsulinemia only affects insulin-re-
sponsive tissues like skeletal muscle.
MUSCLE GROWTH CAPACITY AND 
METABOLIC FUNCTION
Skeletal muscle accounts for 40% of total body 
mass and consumes 65% of the body’s total glucose 
(DeFronzo et  al., 1981). With metabolic rates 
highly responsive to endocrine regulation, muscle 
is a key factor in metabolic homeostasis as well as 
a primary target for nutrient sparing in the IUGR 
fetus (Brown, 2014). Consequently, reduced muscle 
growth capacity and altered metabolic function are 
key developmental adaptations that help reappor-
tion limited nutrient and O2 supplies during late 
gestation (Yates et  al., 2011a, 2012b). Although 
critical for fetal survival, these programmed mech-
anisms of nutrient sparing continue to reduce nu-
trient utilization by muscle in offspring despite 
sufficient postnatal nutrient availability.
Skeletal Muscle Mass and Growth Efficiency
Throughout life, IUGR-born humans have less 
skeletal muscle (Kensara et  al., 2005; Yliharsila 
et  al., 2007) that strongly correlates with meta-
bolic dysfunction due to the tissue’s role in glucose 
homeostasis (Kim et  al., 2014). Ultrasonography 
shows that slower muscle growth is present well 
before birth (Padoan et al., 2004; Larciprete et al., 
2005) and continues throughout infancy and child-
hood (Hediger et al., 1998). Dietary nutrients that 
would normally be used for muscle growth are 
instead stored in central fat deposits that mani-
fest in abdominal obesity in children as young as 
10 yr of age (Zarrati et al., 2013). Increased body 
fat can lead to secondary pathologies such as sys-
temic low-grade inflammation and hyperlipidemia 
(Ampem et al., 2016; Veiga-Lopez et al., 2016) that 
further disrupt metabolic function. Similar adap-
tive programming in livestock results in poor feed 
conversion and body composition (De Blasio et al., 
2007; Madsen and Bee, 2015), as catch-up growth 
is driven by fat deposition rather than muscle 
growth (De Blasio et  al., 2010; Liu et  al., 2015). 
Consequently, carcasses of IUGR livestock have 
reduced merit (decreased weight, excessive 12th-rib 
fat thickness, and decreased subprimal weight) 
(Hegarty and Allen, 1978; Powell and Aberle, 1980; 
Greenwood et al., 1998, 2000; Gondret et al., 2005), 
which substantially affects profit. P.L. Greenwood 
has comprehensively documented the detriment of 
IUGR to carcass quality; longissimus dorsi muscles 
that comprise the loin are substantially lighter and 
smaller in diameter in IUGR heifers at 30 mo of age 
(Greenwood and Cafe, 2007). For each kilogram 
less that an animal weighs at birth, its HCW, LM 
area, and total retail yield at slaughter are reduced 
by an average of 2.71  kg, 0.52  cm2, and 1.97  kg, 
respectively (Robinson et al., 2013). In fact, birth-
weight differences explain up to 37% of variation in 
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carcass weight and yield independently of postna-
tal diet. Similar deficits occur in IUGR-born lambs, 
as carcass yield strongly correlates with birthweight 
and crown-rump length (De Blasio et  al., 2007). 
Likewise, IUGR-born pigs produce carcasses with 
less meat and more omental and subcutaneous fat 
regardless of their diet (Madsen and Bee, 2015). 
Current USDA-AMS Daily Beef Reports (April 
20, 2018)  indicate the potential reduction in final 
value that an IUGR steer carcass might receive. 
Discounts for decreased USDA Yield Grade (re-
duction of ~$10.71/45.4 kg/animal for USDA Yield 
Grade 4)  and reduced intramuscular fat depos-
ition (USDA Select vs. Choice) would result in a 
combined reduction of $23.13/45.4 kg/animal. Per 
current USDA-AMS reported average dressed steer 
HCW (403 kg) and negotiated prices for domestic 
steers ($189.78/45.4  kg), this would equate to a 
$205.40 reduction in carcass value. Additionally, a 
reduction in HCW of 45.4 kg would equate to a loss 
of $189.78/animal. The combination of reduced 
HCW and decreased carcass merit would equate 
to a loss of $395.18/animal. Clearly, the financial 
implications of IUGR livestock are not trivial.
In ruminants and humans, muscle fiber hyper-
plasia ceases early in the third trimester (Robelin 
et al., 1991; Wilson et al., 1992). Subsequent muscle 
growth occurs by fiber hypertrophy that is facil-
itated by increased myonuclear content, which 
amplifies protein synthesis capacity (Davis and 
Fiorotto, 2009; Ten Broek et  al., 2010). However, 
muscles in IUGR infants and lambs contain fewer 
myonuclei per fiber at birth, resulting in less DNA, 
RNA, and protein per fiber (Widdowson et  al., 
1972; Greenwood et  al., 1999; Greenwood et  al., 
2000). Myonuclei are postmitotic and accumulation 
requires incorporation of muscle stem cells called 
myoblasts that proliferate, terminally differentiate, 
and then fuse with adjacent fibers, effectively donat-
ing their nuclei to the fiber (Davis and Fiorotto, 
2009; Ten Broek et  al., 2010). Myoblast function 
is rate limiting for muscle growth (Pavlath et  al., 
1989; Allen et  al., 1999), and myoblasts isolated 
from IUGR fetal sheep exhibit intrinsically reduced 
functional capacity (Yates et al., 2014). Specifically, 
IUGR myoblast cultures contained fewer myogenic 
differentiation 1 (MyoD)-positive cells and reduced 
replication rates whether supplemented with fetal 
bovine serum, control fetal sheep serum, or IUGR 
fetal sheep serum. This coincided with reduced pro-
liferating cell nuclear antigen (PCNA)-positive myo-
blasts in IUGR semitendinosus cross-sections near 
term and at 28 d of age (Yates et al., 2014; Camacho 
et al., 2016b). Moreover, IUGR myoblasts cultured 
in differentiation media (2% fetal bovine serum) for 
4 d had fewer myogenin-positive and desmin-pos-
itive cells than control fetal myoblasts (Yates, un-
published data). This explains altered myoblast 
populations and reduced fiber sizes in IUGR hind-
limb muscles near term (Yates et al., 2014, 2016) and 
at 28 d of age (Camacho et al., 2016b), as postna-
tal muscle stem cells (satellite cells) originate from 
fetal myoblast precursors (Greenwood et al., 1999; 
Messina and Cossu, 2009). Insulin promotes pro-
liferation and differentiation of myoblasts (Allen 
et al., 1985) via AKT-mediated signaling pathways 
(Sumitani et  al., 2002), and insulin infusion into 
uncompromised sheep fetuses increases myoblast 
proliferation (Brown et al., 2016b). However, skel-
etal muscle AKT content is reduced in IUGR sheep 
fetuses (Thorn et al., 2009) and adult rats (Camm 
et  al., 2011). Also, insulin activation of AKT is 
impaired in muscle from IUGR-born men (Jensen 
et al., 2008) and rats despite greater insulin-stimu-
lated insulin receptor substrate 1 phosphorylation 
(Rueda-Clausen et  al., 2011). Impaired insulin–
AKT coupling is particularly noteworthy, as insulin 
is an important promoter of muscle growth and glu-
cose metabolism.
Skeletal Muscle Metabolism and Glucose 
Homeostasis
Fetal metabolic adaptations predispose IUGR-
born offspring to metabolic diseases that lower 
quality of life (Vickers et al., 2000; Newsome et al., 
2003). Glucose intolerance and obesity rates are 
profoundly higher in IUGR-born individuals even 
at very young ages (Flanagan et al., 2000; Ong et al., 
2000; Mericq et al., 2005). Poor insulin sensitivity 
and reduced glucose oxidation, which are hallmark 
characteristics of diabetics (Vind et al., 2012), are 
present in IUGR-born children by 12 yr of age 
even at normal bodyweights (Jornayvaz et al., 2004; 
Dulloo, 2006). A pair of pivotal studies in IUGR 
fetal sheep indicates that deficits in systemic glu-
cose oxidation arise prenatally despite normal rates 
of whole-body glucose utilization (Limesand et al., 
2007; Brown et al., 2015). Fractional reductions in 
glucose oxidation also coincide with greater lactate 
production, which indicates a metabolic shift from 
oxidation to anaerobic glycolysis. Interestingly, 
when hypoinsulinemia is corrected in IUGR fetal 
sheep via infusion, glucose utilization increases 
while O2 consumption (an indirect measure of oxi-
dative metabolism) does not (Thorn et  al., 2013). 
Instead, circulating lactate concentrations further 
increase, indicating that the metabolic shift is not 
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dictated by hypoinsulinemia but rather by select-
ively impaired sensitivity of glucose oxidation to in-
sulin. Impaired proximal insulin signaling in muscle 
from IUGR fetal sheep and adult humans (Ozanne 
et al., 2005; Thorn et al., 2009) may be explained in 
part by altered fiber type proportions.
Skeletal muscle fiber types differ in their meta-
bolic rates, mitochondrial densities, and respon-
siveness to insulin and other metabolic regulators 
(Henriksen et al., 1990; Mackrell and Cartee, 2012). 
Specifically, insulin sensitivity and glucose oxida-
tion rates are greatest in type I  or slow oxidative 
fibers, intermediate in type IIa or fast oxidative 
and/or glycolytic fibers, and lowest in type IIx or 
fast glycolytic fibers. Semitendinosus and biceps fe-
moris muscles frosm IUGR fetal sheep express pro-
portionally fewer type I fibers and total oxidative 
fibers (types I and IIa) near term (Yates et al., 2016). 
Flexibility in fiber type composition throughout 
postnatal life is critical to maintaining metabolic 
homeostasis through changing physiological states 
(Costagliola et al., 2016). Our results indicate that 
fiber type plasticity is reduced by IUGR adapta-
tions (Yates et  al., 2016), which likely contributes 
to metabolic dysfunction in offspring. In fact, we 
report that the shift in glucose metabolism is mus-
cle-centric and is retained in IUGR-born lambs in-
dependent of adipose-driven catch-up growth and 
despite normal circulating glucose, insulin, cortisol, 
epinephrine, and norepinephrine (Camacho et al., 
2016a). In pregnant sheep, we recently observed 
that sustained periods of maternofetal inflamma-
tion in the early third trimester (days 100 to 115 of 
gestation, term = 150 d) induced by serial maternal 
administration of bacterial endotoxin recapitulates 
fetal growth restriction, deficient skeletal muscle 
glucose oxidation, and greater lactate production 
(Merrick et al., 2017). These results were consistent 
with altered metabolic regulation by stress compo-
nents (Cadaret et al., 2017a, 2017b).
ADRENERGIC AND INFLAMMATORY 
ADAPTATIONS
Adrenergic and Inflammatory Regulation of 
Muscle Growth
Catecholamines and inflammatory cytokines 
are important regulators of myoblast function 
and muscle growth (Barnes et  al., 2017; Merrick 
et  al., 2017). Adrenergic regulation is primarily 
facilitated by β2 receptors which are the most 
highly expressed isoform in skeletal muscle, al-
though β1 receptors and to a lesser extent β3 and 
α1D receptors are also present (Kim et al., 1991; Shi 
et al., 2017). Growth studies in animals have led to 
the use of isoform-specific β adrenergic agonists as 
growth-promoting feed supplements for finishing 
livestock, which can increase meat yield of feedlot 
cattle by up to 40% (Johnson et al., 2014). In a pre-
liminary study, proliferation of primary myoblasts 
from steers was increased after 48-h incubation 
with the β2 agonist zilpaterol HCl but not with the 
β1 agonist ractopamine HCl (Yates, unpublished 
data). Our preliminary findings in L6 myoblasts 
show that acute (4 h) incubation with epinephrine 
in the absence of insulin reduces proliferation rates 
but longer exposure (48 to 96 h) increases prolifer-
ation (Riley et al., 2016).
Myoblast regulation by inflammatory cytokines 
is quite complex (Kumar et  al., 2012; Pillon et  al., 
2013). For example, TNFα and TNF-related weak in-
ducer of apoptosis (TWEAK) stimulate proliferation 
in cultured myoblasts but strongly suppress differen-
tiation and fusion (Kumar et al., 2012; Trendelenburg 
et al., 2012; Otis et al., 2014). Furthermore, muscle 
fiber size is reduced by both the knockout of and 
overexposure to inflammatory cytokines (Dogra 
et al., 2007; Kumar et al., 2012; Pillon et al., 2013). 
In an unpublished preliminary study with myoblasts 
isolated from mature cows, we observed 10% fewer 
differentiated (myogenin-positive) myoblasts after 4 d 
when media was spiked with TNFα.
Adrenergic and Inflammatory Regulation of Muscle 
Metabolism
Catecholamines and inflammatory cytokines 
also regulate muscle metabolism (Fernandes et al., 
2014; Barnes et  al., 2017; Cadaret et  al., 2017b; 
Merrick et al., 2017). Acute stimulation of primary 
rat muscle and differentiated bovine myoblasts 
with the β2 agonist zilpaterol HCl increased basal 
and insulin-stimulated glucose oxidation with little 
impact on glucose uptake (Cadaret et  al., 2017b; 
Merrick et  al., 2017). Conversely, acute stimula-
tion with the β1 agonist ractopamine HCl did not 
increase glucose oxidation and antagonized insu-
lin-stimulated AKT phosphorylation. Zilpaterol 
supplementation to wethers for 21 d prior to har-
vest increased glucose oxidation in isolated hind-
limb muscle, but ractopamine did not (Barnes 
et al., 2017).
Like β2 agonists, inflammatory cytokines dir-
ectly stimulate acute muscle glucose oxidation. 
Primary rat and fetal sheep muscle incubated with 
TNFα or IL-6 in the absence of insulin exhibited 
greater glucose oxidation rates (Cadaret et  al., 
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2017b; Merrick et al., 2017). However, the inflam-
matory cytokines impaired insulin-stimulated AKT 
phosphorylation, and thus insulin did not increase 
glucose oxidation in muscle incubated with either 
TNFα or IL-6. Sustained inflammation created 
substantial insulin resistance in ewes adminis-
tered a large intravenous bolus of bacterial endo-
toxin; insulin-to-glucose ratios were comparable to 
controls after 2 h but were increased after 4 h and 
remained greater through 24 h (Yates et al., 2011b).
Adaptive Changes in Adrenergic and Inflammatory 
Regulation
We previously postulated that deficient growth 
and glucose metabolism in IUGR skeletal muscle 
are due to adaptive changes in adrenergic and in-
flammatory regulation. Preliminary findings indi-
cate that differences in adrenergic regulation may 
be due to changes in relative proportions of β re-
ceptor isomers. Gene expression for β2 receptors 
is reduced relative to that of β1 and β3 receptors 
in IUGR fetal and neonatal muscle and in fetal 
myoblasts (Yates et  al., 2012b). Since β2 activity 
stimulates growth and metabolism, the reduction in 
relative β2-to-β1/β3 signaling may represent the in-
trinsic deficit underlying impaired IUGR myoblast 
function and muscle hypertrophy (Yates et al., 2014, 
2016). Moreover, β2 adrenergic activity enhances 
insulin action, whereas β1 and β3 adrenergic ac-
tivity disrupt insulin signaling (Jost et  al., 2005; 
Cadaret et  al., 2017b). Less relative β2 activity is 
also consistent with the metabolic phenotype of 
IUGR muscle, as β2 stimulation increases glu-
cose oxidation and insulin activity (Cadaret et al., 
2017b), likely via mammalian target of rapamycin 
complex (mTORC)-mediated pathways (Sato et al., 
2014; Posont et al., 2017). Conversely, β1 stimula-
tion diminishes glucose oxidation and insulin sig-
naling (Hoeks et al., 2003; Cadaret et al., 2017b). 
The shift in β adrenergic activity may also have in-
direct implications on muscle glucose metabolism, 
including the loss of β2-mediated anti-inflamma-
tory effects (Silva et al., 2014) and greater β1-me-
diated disruption of IGF activity (Walker et  al., 
2010).
In addition to adrenergic changes, basal inflam-
mation status is greater in IUGR-born offspring. In 
rats, IUGR increased circulating TNFα concentra-
tions in 21-d-old male offspring, despite substantial 
catch-up growth (Riddle et  al., 2014). Circulating 
TNFα and toll-like receptor 9 (TLR9) concentra-
tions were also higher in IUGR-born rats at 8 wk 
(Oliveira et al., 2017) and 9 mo of age (Desai et al., 
2009), and hepatic TNFα and IL-6 concentrations 
were greater at 12 mo (Tarry-Adkins et al., 2016). In 
IUGR-born mice, catch-up growth had normalized 
body weights by 2 wk of age, yet IL-6, IL-1β, and 
TNFα were all increased at 10 wk (Chisaka et al., 
2016). Chronic low-grade inflammation almost 
certainly contributes to muscle dysregulation due 
to the effects of inflammatory cytokines on myo-
blast function (Kumar et al., 2012; Trendelenburg 
et  al., 2012; Otis et  al., 2014) and muscle hyper-
trophy (Dogra et al., 2007; Bhatnagar et al., 2012). 
Preliminary results in rats show amplified inflam-
matory activity prenatally, as maternal inflam-
mation at mid-gestation increased fetal plasma 
TNFα by ~67% at term (Cadaret et  al., 2017a). 
These pups also exhibited evidence of inflamma-
tory adaptations with skeletal muscle tissues; total 
resident macrophages and growth-promoting M2 
macrophages were reduced in hindlimb muscles. 
This coincided with fewer MyoD-positive and 
more myogenin-positive hindlimb myoblasts, indi-
cating precocious differentiation (Cadaret et  al., 
2017a). Unpublished preliminary results in IUGR 
fetal sheep indicate enhanced cytokine stimulus-re-
sponse coupling as muscle content of the nuclear 
factor kappa-light-chain-enhancer of activated B 
cells (NFκB)-sequestering protein, nuclear factor 
of kappa light polypeptide gene enhancer in B-cells 
inhibitor (IκB), is reduced. In addition, gene ex-
pression for TNFα and TNF receptor 1 (TNFR1) is 
increased in muscle of IUGR fetal sheep and white 
blood cells of IUGR fetal rats. The combination of 
greater basal inflammation and enhanced respon-
siveness to cytokines along with adrenergic changes 
likely mediate muscle dysregulation.
SUMMARY AND CONCLUSIONS
Intrauterine growth restriction is the result of 
fetal adaptations to poor intrauterine conditions. 
This adaptive programming benefits fetal survival 
but leads to a multitude of problems after birth. 
Humans and animals that experience IUGR have 
much greater rates of perinatal and/or neonatal 
morbidity and mortality, and those that survive have 
reduced muscle mass, increased fat deposition, and 
are at much greater risk for metabolic dysfunction 
throughout life. In livestock, IUGR-born animals 
exhibit low birthweight, inefficient growth, reduced 
carcass quality, and less lean product. In humans, 
IUGR is associated with reduced muscle mass and 
strength, greater childhood obesity, and increased 
risk for type-2 diabetes, hypertension, and other 
conditions of metabolic syndrome in adulthood. 
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Maternofetal stress caused by any of a number of 
different environmental, nutritional, and toxicity 
stressors diverts maternal blood flow away from 
the gravid uterus, thus stunting placental develop-
ment. These placentas, characterized by poor vas-
cularity and reduced permeability, fail to provide 
the fetus with sufficient O2 and nutrients during the 
later stages of gestation. As the fetus progressively 
outgrows its stunted placenta, it becomes increas-
ingly hypoxemic and hypoglycemic, resulting in 
sustained fetal stress responses that include hyper-
catecholaminemia and inflammation. As these 
conditions become chronic, the fetus develops two 
key muscle-centric adaptations to restrict nonvital 
use of nutrients. First, skeletal muscle growth is 
disproportionally reduced via impaired myoblast 
function, which results in the hallmark asymmetric 
fetal growth restriction. Second, muscle glucose 
metabolism is reduced via inhibition of insulin se-
cretion and reduction of glucose oxidation. Our re-
cent findings indicate that reduced responsiveness 
to β2 adrenergic regulation and enhanced respon-
siveness to inflammatory regulation in IUGR skel-
etal muscle may be key mechanisms underlying the 
IUGR metabolic phenotype. Moreover, these sys-
tems may provide unique targets for interventions 
and treatments to improve outcomes in IUGR-
born offspring.
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